[Clinical study of non-alcoholic fatty liver disease and its combined the chronic HBV infection]
- PMID: 29056013
- DOI: 10.3760/cma.j.issn.1007-3418.2017.08.012
[Clinical study of non-alcoholic fatty liver disease and its combined the chronic HBV infection]
Abstract
Objective: to compared with clinical data between nonalcoholic fatty liver disease (NAFLD) and Chronic HBV infection with NAFLD, and to explore the relationship between HBV infection and hepatic steatosis. Methods: A total of 81 patients with clinical data in the Department of Infectious Diseases in Henan Provincial People's Hospital from June 2013 to June 2016 were enrolled and divided into NAFLD group and HBV combined NAFLD group.Comparison of The levels of liver function (ALT, AST, ALP, GGT), blood lipid (TC, TG, HDL, LDL), blood glucose (GLU), uric acid (UA), hepatic fibrosis (S) and inflammation (G) And hepatic steatosis (F), and to explore the relationship between HBV infection and hepatic steatosis. The independent samples t-test or Wilcoxon two -sample test was used for comparison of continuous data,and the chi-square test was used for comparison of categorical data. Multinomial Logistic regression was used to analyze The risk factors of hepatic steatosis, P < 0.05 was considered statistically significant. Results: A total of 81 subjects were enrolled, with 31 in the NAFLD group and 36 in the HBV with NAFLD group. Baseline level comparison: ALT (t = -4.379, P < 0.01)、AST (t = -3.847, P < 0.01) 、GGT (t = -2.763, P < 0.01) and F (χ(2) = 20.341, P < 0.01), There were significant difference (P < 0.05); There were no significant differences in the levels of blood lipids, blood glucose, uric acid, inflammation and fibrosis. e antigen status of liver steatosis is a risk factor, hepatitis B viral load and liver steatosis has nothing to do. Conclusion: In addition to HBV infection-related indicators, it is difficult to distinguish between NAFLD and NAFLD combined with HBV differences; HBV infection and hepatic steatosis have a certain relationship.
目的: 比较非酒精性脂肪性肝病(NAFLD)与慢性乙型肝炎病毒(HBV)感染合并NAFLD者临床资料的差异,以及探索HBV感染与肝脏脂肪变的关系。 方法: 收集2014年6月至2016年6月住院NAFLD患者的临床资料,分为NAFLD组、HBV合并NAFLD组。比较两组患者肝功能指标(丙氨酸氨基转移酶、天冬氨酸氨基转移酶、碱性磷酸酶、γ-谷氨酰转移酶)、血脂指标(总胆固醇、甘油三酯、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇)、血糖、尿酸、肝纤维化程度、炎症水平分级和肝脂肪变程度的差异,分析HBV感染与肝脂肪变的关系。服从正态分布的计量资料比较用独立样本t检验,非正态分布的计量资料比较用Wilcoxon秩和检验,计数资料比较采用χ(2)检验,肝脂肪变相关危险因素的探讨采用多项分类logistic回归分析。 结果: 共纳入81例研究对象(NAFLD组45例、HBV合并NAFLD组36例),基线水平比较:丙氨酸氨基转移酶(t = -4.379,P<0.01)、天冬氨酸氨基转移酶(t = -3.847,P<0.01)、γ-谷氨酰转移酶(t = -2.763,P<0.01)以及肝脏脂肪变程度(χ(2) = 20.341,P<0.01)的差异均有统计学意义,血脂指标、血糖、尿酸、炎症水平、纤维化程度的差异均无统计学意义(P值均>0.05)。logistic回归分析显示:HBeAg状态与肝脂肪变相关,HBV DNA载量与肝脂肪变无关。 结论: 除HBV感染相关指标外,难以区别慢性HBV感染合并NAFLD与单纯NAFLD的差异;HBV感染与肝脏脂肪变有一定联系。.
Keywords: Fatty liver; Hepatitis B virus; Pathology.
Similar articles
-
[Study of reactive oxygen species and adiponectin for chronic HBV infection combined with nonalcoholic fatty liver diseases].Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):247-253. doi: 10.3760/cma.j.cn501113-20191231-00486. Zhonghua Gan Zang Bing Za Zhi. 2020. PMID: 32306658 Chinese.
-
Relations of hepatic steatosis with liver functions, inflammations, glucolipid metabolism in chronic hepatitis B patients.Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5640-5646. doi: 10.26355/eurrev_201809_15830. Eur Rev Med Pharmacol Sci. 2018. PMID: 30229840
-
[Quantitative detection and clinical value of CD44 in patients with nonalcoholic fatty liver disease].Zhonghua Gan Zang Bing Za Zhi. 2019 Dec 20;27(12):994-1000. doi: 10.3760/cma.j.issn.1007-3418.2019.12.012. Zhonghua Gan Zang Bing Za Zhi. 2019. PMID: 31941262 Chinese.
-
Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact.Dig Dis Sci. 2015 Dec;60(12):3513-24. doi: 10.1007/s10620-015-3772-z. Epub 2015 Jun 26. Dig Dis Sci. 2015. PMID: 26112990 Review.
-
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.Atherosclerosis. 2014 Jan;232(1):99-109. doi: 10.1016/j.atherosclerosis.2013.10.030. Epub 2013 Nov 6. Atherosclerosis. 2014. PMID: 24401223 Review.
Cited by
-
FABP1 Polymorphisms Contribute to Hepatocellular Carcinoma Susceptibility in Chinese Population with Liver Cirrhosis: A Case-Control Study.J Cancer. 2018 Oct 20;9(22):4294-4300. doi: 10.7150/jca.27301. eCollection 2018. J Cancer. 2018. PMID: 30519332 Free PMC article.
-
Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysis.Mol Med Rep. 2019 Jan;19(1):320-326. doi: 10.3892/mmr.2018.9619. Epub 2018 Nov 2. Mol Med Rep. 2019. PMID: 30387826 Free PMC article.
-
Neutrophil-lymphocyte ratio is associated with worse outcomes in patients with cirrhosis: insights from the PRO-LIVER Registry.Intern Emerg Med. 2025 Aug;20(5):1371-1380. doi: 10.1007/s11739-025-03955-x. Epub 2025 May 20. Intern Emerg Med. 2025. PMID: 40392481 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous